|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Kyle Brauer Boone (private practice, United States) , Patrick Armistead-Jehle , Ginger Arnold , Bradley N. AxelrodPublisher: Guilford Publications Imprint: Guilford Press Edition: 2nd edition Weight: 1.430kg ISBN: 9781462545551ISBN 10: 1462545556 Pages: 710 Publication Date: 02 July 2021 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In stock We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsBoone has delivered a single, invaluable resource for cutting-edge information about assessing feigned cognitive impairment. In the second edition of this essential resource, a dream team of contributors survey the literature in this burgeoning field. The 29 chapters provide up-to-date, in-depth coverage of the research available to guide use of PVTs and SVTs with the broad range of populations that neuropsychologists assess. The second edition of this neuropsychology classic will be of interest to graduate students, interns, and fellows, as well as seasoned investigators and clinicians. --Yossef S. Ben-Porath, PhD, ABPP, Department of Psychological Sciences, Kent State University The first edition of this work has been a staple reference book for clinical neuropsychologists for more than a dozen years. The second edition is not merely an update, but reflects the reconceptualization and evolution of performance validity testing across the vast corpus of scientific literature that has accumulated in neuropsychology. This comprehensive guide covers research methodology, detection of feigned responses across multiple cognitive domains, and considerations for specific clinical populations. The volume is invaluable for any clinical neuropsychologist, as well as for graduate students and trainees learning the nuances of the assessment of test validity--the bedrock of accurate test interpretation--in clinical and forensic practice. --Bernice A. Marcopulos, PhD, ABPP, Department of Graduate Psychology, James Madison University; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine Boone and her colleagues are at the forefront of detecting the exaggeration of symptoms and impairments for secondary gain, a growing area in neuropsychology over the last 30 years. This expanded second edition provides the latest research findings and assessment techniques to help practitioners carefully evaluate patients to identify those with legitimate impairments. This is a valuable book for clinician-scientists who conduct forensic evaluations and/or teach graduate neuropsychological assessment courses. It furthers the discussion of unique dilemmas and continuing legal reforms related to expert testimony and evidence law. --Paul M. Kaufmann, JD, PhD, ABPP, Senior Attorney, University of Texas System; private practice in forensic neuropsychology, San Antonio Boone's decades of clinical and forensic assessment experience, scholarly research, and test development are paying enormous dividends to the profession. With an outstanding cadre of chapter authors, Boone has brilliantly updated one of the most important volumes in forensic neuropsychology. This book is required reading for neuropsychologists new to forensic practice as well as for career professionals. It is an essential reference for those who want to conduct assessments and form opinions with a solid empirical basis. New and updated chapters provide a look in the rearview mirror at where the field has been, and a look to where we need to go in the future. --Joel E. Morgan, PhD, ABPP-CN, independent practice, Morristown, New Jersey Author InformationKyle Brauer Boone, PhD, ABPP, ABCN, has a private practice in Torrance, California, and is Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles. She has published six books and over 125 peer-reviewed research articles, including many in the area of development and validation of tests to detect feigned cognitive symptoms. She has also published two tests used to assess for performance validity on neuropsychological exams: the b Test and the Dot Counting Test. Dr. Boone served on the committee that developed the practice guidelines for clinical neuropsychology published by the American Academy of Clinical Neuropsychology in 2007, and she was an invited attendee of the 25-member consensus conference that developed the practice guidelines for the use of neurocognitive performance validity tests published by the American Academy of Clinical Neuropsychology in 2009 and updated in 2021. She is board certified through the American Board of Clinical Neuropsychology, is a Fellow of the American Psychological Association, and is the 2020 recipient of the Ralph M. Reitan Award for Clinical Excellence from the National Academy of Neuropsychology. Tab Content 6Author Website:Countries AvailableAll regions |